<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药云端工作室 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T20:25:23+08:00</updated>
  <subtitle>医药行业领先的智库，连接政策与市场的桥梁</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>药品招采新玩法，浙江启动小单元竞价</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/5zKGT7wdg5UJg6m17O43ZQ</id>
    <link href="https://mp.weixin.qq.com/s/5zKGT7wdg5UJg6m17O43ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>省采出来了！安徽最高降幅76.55%，江西10家企业拟中选</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/XESyAvyyDCAUS9CIgDL_WA</id>
    <link href="https://mp.weixin.qq.com/s/XESyAvyyDCAUS9CIgDL_WA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DIP试点名单来了，71个城市纳入（附名单）</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/2LivNiEU4U7zQHwHDXCMuw</id>
    <link href="https://mp.weixin.qq.com/s/2LivNiEU4U7zQHwHDXCMuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11.16广州，风轻老师将与您分享《市场准入方式的新思考》</title>
    <updated>2020-11-06T19:03:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/12kAI4vLffuM10kKu5lueQ</id>
    <link href="https://mp.weixin.qq.com/s/12kAI4vLffuM10kKu5lueQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冠脉支架国采结果出炉，10产品拟中选，国家医保局做出回应（视频+文字）</title>
    <updated>2020-11-05T16:51:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/ekEqgJSIxlOCzRRRr5QgNw</id>
    <link href="https://mp.weixin.qq.com/s/ekEqgJSIxlOCzRRRr5QgNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>省级集采，一线强省：浙江8个，河南31个， 江苏与原研药价差大的品种……</title>
    <updated>2020-11-05T16:51:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/Gzvy1O9p_carljwSq4YExg</id>
    <link href="https://mp.weixin.qq.com/s/Gzvy1O9p_carljwSq4YExg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>河北挂网细则出台，联动全国最低价，5类情形禁止挂网</title>
    <updated>2020-11-05T16:51:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/gzNYtsisZQDvQcDn_WZFDA</id>
    <link href="https://mp.weixin.qq.com/s/gzNYtsisZQDvQcDn_WZFDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11.16广州，聂四江将与您分享《市场准入人员的职业发展之路》</title>
    <updated>2020-11-05T16:51:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/ZCb3AwiINT0eCwsD53b7Cw</id>
    <link href="https://mp.weixin.qq.com/s/ZCb3AwiINT0eCwsD53b7Cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重点监测：这些药品或可替代国采中选品种（附明细）</title>
    <updated>2020-11-04T18:57:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/Kn2-JVgwgaiqnAyb4dFLRw</id>
    <link href="https://mp.weixin.qq.com/s/Kn2-JVgwgaiqnAyb4dFLRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏首批111个省医保目录品种，本月起正式被剔除（附全国情况）</title>
    <updated>2020-11-04T18:57:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/JFpVff06pGFHtQgcmexwhQ</id>
    <link href="https://mp.weixin.qq.com/s/JFpVff06pGFHtQgcmexwhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贵州出台医保“结余留用”政策，未中选品种可有活路？</title>
    <updated>2020-11-04T18:57:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/jicw_J7lVAqcuFmYh1hGhA</id>
    <link href="https://mp.weixin.qq.com/s/jicw_J7lVAqcuFmYh1hGhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11.16广州，点苍鹤将与您分享《带量采购时代的医药政策和市场环境》</title>
    <updated>2020-11-04T18:57:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/iQ4QNojQqMScsvWACR08ng</id>
    <link href="https://mp.weixin.qq.com/s/iQ4QNojQqMScsvWACR08ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一年两批左右，第四批国采启动不远了！</title>
    <updated>2020-11-03T21:22:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/PEQ-HAd1rhXjEiOGvc1dAA</id>
    <link href="https://mp.weixin.qq.com/s/PEQ-HAd1rhXjEiOGvc1dAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不得“一刀切”停用未中选药品，山东、北京等地发文（附全国落地情况）</title>
    <updated>2020-11-03T21:22:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/fdHlSq-VO_U99C5MnJHagQ</id>
    <link href="https://mp.weixin.qq.com/s/fdHlSq-VO_U99C5MnJHagQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11.16广州，我们将发布《中国药品采购政策研究报告2020》</title>
    <updated>2020-11-03T21:22:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/ZOI4rWe8DOZwaULxMDDGOA</id>
    <link href="https://mp.weixin.qq.com/s/ZOI4rWe8DOZwaULxMDDGOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家医保局：国采药品使用比例不因医院等级而不同</title>
    <updated>2020-11-02T18:21:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/BGoir-LshfTVi6wedDRprg</id>
    <link href="https://mp.weixin.qq.com/s/BGoir-LshfTVi6wedDRprg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《中国上市药品目录集》即将更名，收录品种也将调整！</title>
    <updated>2020-11-02T18:21:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/AUPctHCshl7cxBDw-aQl8Q</id>
    <link href="https://mp.weixin.qq.com/s/AUPctHCshl7cxBDw-aQl8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扩大“互联网+”医保支付范围，支持复诊处方流转</title>
    <updated>2020-11-02T18:21:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/I7EyXeEjIxC4rK0rDLnSNA</id>
    <link href="https://mp.weixin.qq.com/s/I7EyXeEjIxC4rK0rDLnSNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11.16广州《中国药品采购政策研究报告2020》将正式发布</title>
    <updated>2020-11-02T18:21:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/MmRr1E1WxhIMrC8l-ls_Fw</id>
    <link href="https://mp.weixin.qq.com/s/MmRr1E1WxhIMrC8l-ls_Fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>莎普爱思滴眼液，因一致性评价问题或将停产；国采第三批陆续执行；77药品纳入临床急需境外新药名单｜云端周报</title>
    <updated>2020-11-01T19:45:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/He_E7bdWZlJeZhS_MCY-CQ</id>
    <link href="https://mp.weixin.qq.com/s/He_E7bdWZlJeZhS_MCY-CQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>